RxDoctor Payments Data

Anne Christopher, MD

Pain Medicine · Chesterfield, MONPI 1598709073

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (30.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Stimwave Technologies Incorporated at 34.2% of the total. Reporting peaked in 2019 at $42,204 and has fallen 68.3% since, to $13,378 in 2025. Among pain medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$104,483in general payments, 2019–2025

Across 701 payments — averaging $149.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stimwave Technologies Incorporated$36K
  • Abbott$30K
  • Boston Scientific$11K
  • Biotronik NRO, Inc.$8K
  • Relievant Medsystems, Inc.$4K
  • Si-bone, Inc.$3K
  • plus $11K from 19 others
$1,151,647in research payments, 2019–2025

Across 370 payments — averaging $3112.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$535K
  • Abbott$480K
  • Vertex$96K
  • Biotronik Inc.$18K
  • Si-bone, Inc.$17K
  • Foundation Fusion Solutions, LLC$4K
  • plus $708 from 1 others

What the payments were for

  • Consulting fees$29,78029%
  • Speaking & faculty fees$20,42920%
  • Travel & lodging$17,14316%
  • Food & beverage$31,80130%
  • Gifts$2,5632%
  • Entertainment$2,7673%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,483 in reported general payments places this provider in the 95th percentile of 124 pain medicine providers in Missouri.

See all pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$423,106
Medicare patients
429
Services billed
53,113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen453$8,733
Tizanidine Hcl529$4,738
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen140$3,908
Pregabalin147$3,022
Gabapentin98$1,789
Lidocaine17$1,162
Tramadol Hcl161$1,150
Hydromorphone Hcl13$839
Cephalexin76$448
Baclofen30$317
Diclofenac Sodium20$264
Celecoxib26$260
Oxycodone Hcl18$250
Cyclobenzaprine Hcl16$155
Acetaminophen-CodeineAcetaminophen With Codeine12$149

Paid to pharmacies, not to this prescriber.

Other pain medicine in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →